Literature DB >> 16117693

The effects of naringin and naringenin on endotoxin-induced uveitis in rats.

Kenji Shiratori1, Kazuhiro Ohgami, Iliyana Ilieva, Xue-Hai Jin, Kazuhiko Yoshida, Satoru Kase, Shigeaki Ohno.   

Abstract

The aim of this study was to investigate the efficacy of naringin and naringenin on endotoxin- induced uveitis (EIU) in rats. EIU was induced in male Lewis rats by a footpad injection of lipopolysaccharide (LPS). The rats were injected intravenously with 0.4, 4, or 40 microg/kg naringin or naringenin. Each compound was administered three times, simultaneously, 30 min before and after the actual LPS injection. The aqueous humor was collected 24 h later from both eyes, and the number of cells infiltrating into the aqueous humor and the aqueous humor protein concentration were measured. The levels of prostaglandin E2 (PGE2) and nitric oxide (NO) were determined. Naringin and naringenin suppressed the development of EIU in a dose-dependent fashion. Both treatments with naringin and naringenin produced reductions in PGE2 and NO concentrations in the aqueous humor. In particular, 40 microM/kg of naringin and naringenin suppressed increases in cell count owing to LPS treatment by 31% and 38%, respectively. The possible mechanism for the antiocular inflammatory effect may be the suppression of PGE2 and NO by naringin and naringenin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16117693     DOI: 10.1089/jop.2005.21.298

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  9 in total

Review 1.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

3.  Protective effects of naringenin eye drops on N-methyl-N-nitrosourea-induced photoreceptor cell death in rats.

Authors:  Jun-Li Lin; Yan-Dong Wang; Yan Ma; Chun-Mei Zhong; Mei-Rong Zhu; Wen-Pei Chen; Bao-Qin Lin
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

4.  Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice.

Authors:  Xiangda Meng; Sijie Fang; Zhuhong Zhang; Yang Wang; Caiyun You; Jingkai Zhang; Hua Yan
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

5.  Analgesic effects of naringenin in rats with spinal nerve ligation-induced neuropathic pain.

Authors:  Chuan Yin Hu; Yun-Tao Zhao
Journal:  Biomed Rep       Date:  2014-03-31

Review 6.  Re-appraising the potential of naringin for natural, novel orthopedic biotherapies.

Authors:  Kristin E Yu; Kareme D Alder; Montana T Morris; Alana M Munger; Inkyu Lee; Sean V Cahill; Hyuk-Kwon Kwon; JungHo Back; Francis Y Lee
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

7.  Painong San, a Traditional Chinese Compound Herbal Medicine, Restores Colon Barrier Function on DSS-Induced Colitis in Mice.

Authors:  Xuelin Rui; Jiacheng Li; Ye Yang; Li Xu; Yang Liu; Mengmeng Zhang; Dengke Yin
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-20       Impact factor: 2.629

8.  Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation.

Authors:  Yu Ma; Jingjing Yang; Yali Zhang; Chunyan Zheng; Zhen Liang; Ping Lu; Fei Song; Yuwei Wang; Junjie Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

9.  Naringenin Improves Ovalbumin-Induced Allergic Asthma in Rats through Antioxidant and Anti-Inflammatory Effects.

Authors:  Seyed Vahid Jasemi; Hosna Khazaei; Sajad Fakhri; Ehsan Mohammadi-Noori; Mohammad Hosein Farzaei
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-04       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.